Tamoxifen-induced non-alcoholic steatohepatitis: where are we now and where are we going?

@article{Osman2007TamoxifeninducedNS,
  title={Tamoxifen-induced non-alcoholic steatohepatitis: where are we now and where are we going?},
  author={K. Osman and M. M. Osman and M. Ahmed},
  journal={Expert Opinion on Drug Safety},
  year={2007},
  volume={6},
  pages={1 - 4}
}
  • K. Osman, M. M. Osman, M. Ahmed
  • Published 2007
  • Medicine
  • Expert Opinion on Drug Safety
  • Tamoxifen is a cheap and effective estrogen-receptor antagonist, used as the adjuvant hormonal treatment of choice in women with estrogen-receptor-positive breast cancer. Tamoxifen-induced non-alcoholic steatohepatitis (NASH) may increase the demand on oncologists, not only with regard to screening for diabetes, but also for the suggested link of NASH with high incidence of coronary heart disease. At present, there is no guideline for treatment of hyperlipidaemia associated with tamoxifen… CONTINUE READING
    37 Citations
    Incidence and risk factors for non-alcoholic steatohepatitis in females treated with tamoxifen for breast cancer.
    • 18
    • PDF
    Risk of fatty liver after long-term use of tamoxifen in patients with breast cancer
    Gene expression profiling of murine hepatic steatosis induced by tamoxifen.
    • 28

    References

    SHOWING 1-10 OF 14 REFERENCES
    Tamoxifen-Induced Steatohepatitis
    • 63
    Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial
    • 169
    • Highly Influential
    • PDF
    CYP17 polymorphism and tamoxifen-induced hepatic steatosis.
    • 8
    Rosuvastatin: A safe and effective treatment for dyslipidaemia associated with non-alcoholic steatohepatitis (NASH)
    • M. Ahmed
    • Medicine
    • Scandinavian journal of gastroenterology
    • 2006
    • 10
    Serum leptin levels are associated with tamoxifen -induced hepatic steatosis
    • 18
    Fatty liver and drugs.
    • 59
    • PDF
    Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease
    • 454
    • PDF
    Mitochondrial injury in steatohepatitis
    • 138
    Non-alcoholic steatoheptatitis. In: Metabolic Syndrome
    • Byrne CD, Wild S (Eds),
    • 2005